HK1117060A1 - Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds - Google Patents
Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compoundsInfo
- Publication number
- HK1117060A1 HK1117060A1 HK08110215A HK08110215A HK1117060A1 HK 1117060 A1 HK1117060 A1 HK 1117060A1 HK 08110215 A HK08110215 A HK 08110215A HK 08110215 A HK08110215 A HK 08110215A HK 1117060 A1 HK1117060 A1 HK 1117060A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nanoparticulate
- aryl
- controlled release
- heterocyclic compounds
- release compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69209605P | 2005-06-20 | 2005-06-20 | |
US11/372,857 US20060240105A1 (en) | 1998-11-02 | 2006-03-10 | Multiparticulate modified release composition |
PCT/US2006/023695 WO2007027273A1 (en) | 2005-06-20 | 2006-06-19 | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1117060A1 true HK1117060A1 (en) | 2009-01-09 |
Family
ID=37809174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08110215A HK1117060A1 (en) | 2005-06-20 | 2008-09-16 | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1901722A4 (en) |
KR (1) | KR20080024206A (en) |
CN (1) | CN101879140A (en) |
AU (1) | AU2006285349A1 (en) |
BR (1) | BRPI0612297A2 (en) |
CA (1) | CA2613474A1 (en) |
EA (1) | EA200800092A1 (en) |
HK (1) | HK1117060A1 (en) |
IL (1) | IL188093A0 (en) |
NO (1) | NO20076628L (en) |
SG (1) | SG162811A1 (en) |
WO (1) | WO2007027273A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0909818A2 (en) * | 2008-03-07 | 2015-10-06 | Pfizer | methods, dosage forms and kit for administering ziprasidone without food |
DE102008045854A1 (en) | 2008-09-05 | 2010-03-11 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | Particles of ziprasidone and a disintegrant containing pharmaceutical composition |
WO2010082855A1 (en) * | 2009-01-15 | 2010-07-22 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation |
WO2011148253A2 (en) | 2010-05-25 | 2011-12-01 | Aurobindo Pharma Limited | Solid dosage forms of antipsychotics |
US9649279B2 (en) | 2013-12-16 | 2017-05-16 | Massachusetts Institute Of Technology | Fortified micronutrient salt formulations |
AU2014364930B2 (en) * | 2013-12-16 | 2017-06-15 | Massachusetts Institute Of Technology | Micromolded or 3-D printed pulsatile release vaccine formulations |
MA41611A (en) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | MILLI-CAPSULE PREPARATIONS CONTAINING FREE POLYINSATURATED FATTY ACIDS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
AU660852B2 (en) * | 1992-11-25 | 1995-07-06 | Elan Pharma International Limited | Method of grinding pharmaceutical substances |
US6150366A (en) * | 1998-06-15 | 2000-11-21 | Pfizer Inc. | Ziprasidone formulations |
US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
DK1126826T6 (en) * | 1998-11-02 | 2019-06-24 | Alkermes Pharma Ireland Ltd | Multiparticulate modified release of methylphenidate |
CN1196486C (en) * | 1999-05-27 | 2005-04-13 | 辉瑞产品公司 | Ziprasidone suspension |
WO2004037289A2 (en) * | 2002-10-25 | 2004-05-06 | Pfizer Products Inc. | Novel injectable depot formulations |
BRPI0414082A (en) * | 2003-09-02 | 2006-10-24 | Pfizer Prod Inc | Sustained-release dosage forms of ziprasidone |
CN101166514A (en) * | 2005-04-13 | 2008-04-23 | 辉瑞产品公司 | Injectable depot formulations and methods for providing sustained release of nanoparticle compositions |
-
2006
- 2006-06-19 CA CA002613474A patent/CA2613474A1/en not_active Abandoned
- 2006-06-19 EP EP06773467A patent/EP1901722A4/en not_active Withdrawn
- 2006-06-19 SG SG201004372-7A patent/SG162811A1/en unknown
- 2006-06-19 EA EA200800092A patent/EA200800092A1/en unknown
- 2006-06-19 AU AU2006285349A patent/AU2006285349A1/en not_active Abandoned
- 2006-06-19 WO PCT/US2006/023695 patent/WO2007027273A1/en active Application Filing
- 2006-06-19 CN CN2010102092071A patent/CN101879140A/en active Pending
- 2006-06-19 BR BRPI0612297-3A patent/BRPI0612297A2/en not_active IP Right Cessation
- 2006-06-19 KR KR1020087001338A patent/KR20080024206A/en not_active Application Discontinuation
-
2007
- 2007-12-12 IL IL188093A patent/IL188093A0/en unknown
- 2007-12-21 NO NO20076628A patent/NO20076628L/en not_active Application Discontinuation
-
2008
- 2008-09-16 HK HK08110215A patent/HK1117060A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006285349A1 (en) | 2007-03-08 |
BRPI0612297A2 (en) | 2010-11-03 |
SG162811A1 (en) | 2010-07-29 |
CA2613474A1 (en) | 2007-03-08 |
WO2007027273A1 (en) | 2007-03-08 |
KR20080024206A (en) | 2008-03-17 |
IL188093A0 (en) | 2008-03-20 |
EA200800092A1 (en) | 2008-06-30 |
EP1901722A1 (en) | 2008-03-26 |
EP1901722A4 (en) | 2011-06-15 |
CN101879140A (en) | 2010-11-10 |
NO20076628L (en) | 2008-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200708260B (en) | Nanoparticulate and controlled release compositions comprising cyclosporine | |
IL244442B (en) | Substituted acylanilide compounds and uses thereof | |
ZA200802602B (en) | Controlled release formulation | |
SG138592A1 (en) | Nanoparticulate and controlled release compositions comprising cephalosporin | |
GB0406819D0 (en) | Controlled release compositions | |
ZA200705384B (en) | Nanoparticulate candesartan formulations | |
IL199006A0 (en) | Nanoparticulate formulations and methods for the making and use thereof | |
IL186609A0 (en) | Nanoparticulate quinazoline derivative formulations | |
ZA200805646B (en) | Controlled release solid preparation | |
PL1959925T3 (en) | Controlled release microparticles | |
IL186778A0 (en) | Stabilized composition | |
ZA200805706B (en) | Controlled release solid preparation | |
GB0621160D0 (en) | Compounds and uses thereof | |
IL187431A0 (en) | Nanoparticulate and controlled release compositions comprising a cephalosporin | |
HK1117060A1 (en) | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds | |
EP2124908A4 (en) | Compounds and uses thereof | |
EP1849481A4 (en) | Composition for external use | |
GB2442366A8 (en) | Nanoparticulate and controlled release compositions comprising prostaglandin derivatives | |
EP2120563A4 (en) | Compounds and uses thereof | |
IL185223A0 (en) | Compounds and uses thereof | |
IL202496A0 (en) | Compounds and uses thereof 849 | |
EP1954253A4 (en) | Nanoparticulate and controlled release compositions comprising cefditoren | |
EP1946780A4 (en) | Controlled release solid preparation | |
ZA200710715B (en) | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds | |
GB0804899D0 (en) | Compound composition and use |